S'abonner

Prenatal alcohol exposure and childhood atopic disease: A Mendelian randomization approach - 25/12/13

Doi : 10.1016/j.jaci.2013.04.051 
Seif O. Shaheen, PhD a, , Clare Rutterford, MSc a, Luisa Zuccolo, PhD b, c, Susan M. Ring, PhD b, George Davey Smith, MD b, c, John W. Holloway, PhD d, A. John Henderson, MD b
a Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, London, United Kingdom 
b School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom 
c Medical Research Council Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Bristol, United Kingdom 
d Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom 

Corresponding author: Seif O. Shaheen, PhD, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, 58 Turner St, London E1 2AB, United Kingdom.

Abstract

Background

Alcohol consumption in western pregnant women is not uncommon and could be a risk factor for childhood atopic disease. However, reported alcohol intake may be unreliable, and associations are likely to be confounded.

Objective

We aimed to study the relation between prenatal alcohol exposure and atopic phenotypes in a large population-based birth cohort with the use of a Mendelian randomization approach to minimize bias and confounding.

Methods

In white mothers and children in the Avon Longitudinal Study of Parents and Children (ALSPAC) we first analyzed associations between reported maternal alcohol consumption during pregnancy and atopic outcomes in the offspring measured at 7 years of age (asthma, wheezing, hay fever, eczema, atopy, and total IgE). We then analyzed the relation of maternal alcohol dehydrogenase (ADH)1B genotype (rs1229984) with these outcomes (the A allele is associated with faster metabolism and reduced alcohol consumption and, among drinkers, would be expected to reduce fetal exposure to ethanol).

Results

After controlling for confounders, reported maternal drinking in late pregnancy was negatively associated with childhood asthma and hay fever (adjusted odds ratio [OR] per category increase in intake: 0.91 [95% CI, 0.82-1.01] and 0.87 [95% CI, 0.78-0.98], respectively). However, maternal ADH1B genotype was not associated with asthma comparing carriers of A allele with persons homozygous for G allele (OR, 0.98 [95% CI, 0.66-1.47]) or hay fever (OR, 1.11 [95% CI, 0.71-1.72]), nor with any other atopic outcome.

Conclusion

We have found no evidence to suggest that prenatal alcohol exposure increases the risk of asthma or atopy in childhood.

Le texte complet de cet article est disponible en PDF.

Key words : Alcohol, ADH1B, Mendelian randomization, prenatal exposure, ALSPAC, pregnancy, birth cohort, asthma, atopy

Abbreviations used : ADH, ALSPAC, GWAS, PCA


Plan


 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 Supported by the UK Medical Research Council, Wellcome Trust grant 092731, and the University of Bristol who provided core support for ALSPAC. L.Z. was funded by a Medical Research Council Population Health Scientist fellowship (grant G0902144). L.Z. and G.D.S. work in a center that receives funding from the MRC (grant G0600705).
 Disclosure of potential conflict of interest: A. J. Henderson has been supported by one or more grants from the UK Medical Research Council and the Wellcome Trust. S. M. Ring has been supported by one or more grants from the UK Medical Research Council (grant 74882) and the Wellcome Trust (grant 076467). L. Zuccolo has been supported by one or more grants from the UK Medical Research Council. The rest of the authors declare that they have no relevant conflicts of interest.


© 2013  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 133 - N° 1

P. 225 - janvier 2014 Retour au numéro
Article précédent Article précédent
  • T cell–derived microvesicles induce mast cell production of IL-24: Relevance to inflammatory skin diseases
  • Irit Shefler, Metsada Pasmanik-Chor, Dvora Kidron, Yoseph A. Mekori, Alon Y. Hershko
| Article suivant Article suivant
  • Real-time differential tracking of human neutrophil and eosinophil migration in vivo
  • Joanna J. Lukawska, Lefteris Livieratos, Barbara M. Sawyer, Tak Lee, Michael O'Doherty, Philip J. Blower, Martin Kofi, James R. Ballinger, Christopher J. Corrigan, Gopinath Gnanasegaran, Ehsan Sharif-Paghaleh, Gregory E.D. Mullen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.